potassium channel blockers

Preferred Label : potassium channel blockers;

MeSH definition : A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS.;

MeSH synonym : blockers, potassium channel; channel blockers, potassium; Potassium Channel Blocker; Blocker, Potassium Channel; Channel Blocker, Potassium;

MeSH annotation : DF: K CHANNEL BLOCK;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D026902;

UMLS CUI

C0872245;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Substance with potassium channel blocker mechanism of action (substance) [SNOMED CT concept]
Indexing information
- 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo(d)imidazol-1-yl)-3-(p-tolyloxy)propan-2-ol [MeSH Supplementary Concept]
- 2-(butane-1-sulfonylamino)-N-(1-(6-methoxypyridin-3-yl)propyl)benzamide [MeSH Supplementary Concept]
- 3-((2-(dipropylamino)-1,2-dipyridin-2-ylethyl)(propyl)amino)propane-1,2-diol [MeSH Supplementary Concept]
- 3-nitro-N-(4-phenoxyphenyl)benzamide [MeSH Supplementary Concept]
- 4-((3-(trifluoromethyl)phenyl)methyl)-2H-1,4-benzothiazin-3(4H)-one [MeSH Supplementary Concept]
- 4-aminopiperidine [MeSH Supplementary Concept]
- 7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-6-(1-(4-(trifluoromethyl)cyclohexyl)-1H-1,2,4-triazol-5-yl)-4,7-dihydropyrazolo(1,5-a)pyrimidine [MeSH Supplementary Concept]
- AamTX protein, androctonus amoreuxi [MeSH Supplementary Concept]
- KMK peptide, tityus stigmurus [MeSH Supplementary Concept]
- RY796 [MeSH Supplementary Concept]
- chukrasone A [MeSH Supplementary Concept]
- chukrasone B [MeSH Supplementary Concept]
- coumarsabin [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- potassium channels [MeSH Descriptor]
Record concept(s)
- potassium channel blockers [MeSH concept]
See also
- anti-arrhythmia agents [MeSH Descriptor]
- katp channels [MeSH Descriptor]
- vasodilator agents [MeSH Descriptor]
See also inter- (CISMeF)
- Potassium channel blocker (disposition) [SNOMED CT concept]
- Product containing potassium channel blocker (product) [SNOMED CT concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-((9-benzyl)fluoren-9-yl)-4-(hexahydro-1H-azepin-1-yl)but-2-yne [MeSH Supplementary Concept]
- 1-(2-amino-4-methanesulfonamidophenoxy)-2-(N-(3,4-dimethoxyphenethyl)-N-methylamino)ethane [MeSH Supplementary Concept]
- 1-(4-methanesulfonamidophenoxy)-3-(N-methyl-3,4-dichlorophenylethylamino)-2-propanol [MeSH Supplementary Concept]
- 2-(N-(2,6-dichlorophenyl)-N-(4-fluorobenzyl)amino)imidazoline [MeSH Supplementary Concept]
- 3-butyl-5-(4-(((2,2-dimethylcyclopent-1-yl)methyl)aminocarbonyl)phenyl)-1,2,4-oxadiazole [MeSH Supplementary Concept]
- 4-Aminopyridine [MeSH Descriptor]
- 5,8-diethoxypsoralen [MeSH Supplementary Concept]
- 6,10-diaza-3(1,3),8(1,4)dibenzena-1,5(1,4)diquinolinacyclodecaphane [MeSH Supplementary Concept]
- 6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane [MeSH Supplementary Concept]
- 8,14-diaza-1,7(1, 4)-diquinolinacyclotetradecaphane [MeSH Supplementary Concept]
- 8-methoxy-2-(1'-methylethyl)-5-methyl-4,5-dihydrofuro(3,2-c)quinolin-4-one [MeSH Supplementary Concept]
- 9-methoxy-2,2,6-trimethyl-2,6-dihydro-5H-pyrrano(3,2-c)quinolin-5-one [MeSH Supplementary Concept]
- Amifampridine [MeSH Descriptor]
- BTS 67582 [MeSH Supplementary Concept]
- BmP01 toxin [MeSH Supplementary Concept]
- BmP02 peptide [MeSH Supplementary Concept]
- BmP02 toxin [MeSH Supplementary Concept]
- BmP03 peptide [MeSH Supplementary Concept]
- BmP03 toxin [MeSH Supplementary Concept]
- BmP05 toxin [MeSH Supplementary Concept]
- BmTXKbeta1 protein, buthus martensii [MeSH Supplementary Concept]
- BmTXKbeta2 peptide [MeSH Supplementary Concept]
- HmK toxin, sea anemone [MeSH Supplementary Concept]
- L 735821 [MeSH Supplementary Concept]
- L 768673 [MeSH Supplementary Concept]
- Lq2 protein, leiurus quinquestriatus [MeSH Supplementary Concept]
- N-(4-fluorophenyl)-N'-phenyl-N'-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine [MeSH Supplementary Concept]
- PNU 99963 [MeSH Supplementary Concept]
- Pi1 toxin [MeSH Supplementary Concept]
- Pi2 toxin [MeSH Supplementary Concept]
- Pi3 toxin, scorpion [MeSH Supplementary Concept]
- Pi4 peptide [MeSH Supplementary Concept]
- S66913 [MeSH Supplementary Concept]
- SGTx1 toxin [MeSH Supplementary Concept]
- ShK neurotoxin [MeSH Supplementary Concept]
- TX1 toxin, buthus [MeSH Supplementary Concept]
- TX1 toxin, heterometrus spinnifer [MeSH Supplementary Concept]
- U 97025E [MeSH Supplementary Concept]
- UCL 1530 [MeSH Supplementary Concept]
- WIN 17317-3 [MeSH Supplementary Concept]
- aek toxin [MeSH Supplementary Concept]
- amiodarone [MeSH Descriptor]
- clamikalant [MeSH Supplementary Concept]
- clofilium [MeSH Supplementary Concept]
- correolide [MeSH Supplementary Concept]
- dendrotoxin I [MeSH Supplementary Concept]
- ditritiocorreolide [MeSH Supplementary Concept]
- dofetilide [MeSH Supplementary Concept]
- hanatoxin [MeSH Supplementary Concept]
- kalicludine [MeSH Supplementary Concept]
- kaliseptine [MeSH Supplementary Concept]
- kappa-conotoxin PVIIA [MeSH Supplementary Concept]
- linopirdine [MeSH Supplementary Concept]
- margatoxin [MeSH Supplementary Concept]
- noxiustoxin [MeSH Supplementary Concept]
- pandinus toxin K-alpha [MeSH Supplementary Concept]
- parabutoxin 3 protein, parabuthus transvaalicus [MeSH Supplementary Concept]
- paxilline [MeSH Supplementary Concept]
- tamulustoxin protein, mesobuthus tamulus [MeSH Supplementary Concept]
- tertiapin [MeSH Supplementary Concept]
- tetraethylammonium [MeSH Descriptor]
- toxin BgK [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Product containing potassium channel blocker (product) [SNOMED CT concept]
- Substance with potassium channel blocker mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients